MedTrace Logo

Soluble ST2 in Patients With Heart Failure"

NCT06426368 · Status: NOT_YET_RECRUITING · Type: OBSERVATIONAL · Enrollment: 100

Last updated 2024-05-23

No results posted yet for this study

Summary

1. The aim of this study was to explore the relationship between peripheral circulating serum soluble suppression of tumorigenicity-2 (sST2) levels and inflammatory biomarkers in patients with heart failure
2. Additive role of sST2 to NPs in of heart failure patients

Conditions

  • Heart Failure Patients

Interventions

DIAGNOSTIC_TEST

ST2

ELISA used to detect levels of ST2 and BNP as inflammatory biomarkers in patients with heart failure

Sponsors & Collaborators

  • Assiut University

    lead OTHER

Principal Investigators

  • Randa Ahmed · Assiut University

  • Hanan Omer · Assiut University

  • Yousra Mamdouh · Assiut University

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-07-01
Primary Completion
2026-07-01
Completion
2027-01-01

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06426368 on ClinicalTrials.gov